August 30, 2011 08:35 ET

Equity Research on Garmin Ltd. and Affymetrix Inc. - Instrument Makers Facing Obstacles

NEW YORK, NY--(Marketwire - Aug 30, 2011) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Scientific & Technical Instruments industry and are offering free analytical research on Garmin Ltd. (NASDAQ: GRMN) and Affymetrix Inc. (NASDAQ: AFFX). Register with us today at to have free access to these research reports.

Scientific and technical instrument manufacturers are facing problems unique to the markets they operate in. Get your free reports on Garmin Ltd. and Affymetrix Inc. at There is no commitment to join. is the Ultimate Trading Environment for investors. If you are considering owning Garmin Ltd. and Affymetrix Inc. then you should sign up for a free membership and our complimentary reports today at Over the last 5 years our returns outpaced any of the major indexes. Sign up today to find out what you are missing.

Navigation device makers continue to be pressured by consumers opting for free services included in their smartphones and tablets. Garmin Ltd. anticipates a 25% decline in the North American personal navigation market this year. To offset waning demand, Garmin has been bundling its navigation devices with live traffic and mapping services. On the plus side, the company is growing revenues in its fitness segment. Garmin Ltd. report is accessible for free by registering today at

Genetic product makers are also contending with growth obstacles. Affymetrix Inc., a leading microarray-based products provider, is facing stiff competition and reduced research and development spending from its customers. The company is expanding into new markets and forging strategic alliances to offset these effects. Affymetrix Inc. report is accessible for free by registering today at

Overall, instrument makers are contending with a variety of revenue threats, but they are actively pursuing solutions to the shifting markets in which they operate. Short-term changes do not appear likely, however the results of these efforts may be seen as early as the first quarter of 2012.

The two Scientific & Technical Instruments stocks research reports are available for free by signing up now on


Shine's Rooms is the brain child of David Shine, a 13 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information